Imaging CAR T-cell kinetics in solid tumors: Translational implications Journal Article


Authors: Skovgard, M. S.; Hocine, H. R.; Saini, J. K.; Moroz, M.; Bellis, R. Y.; Banerjee, S.; Morello, A.; Ponomarev, V.; Villena-Vargas, J.; Adusumilli, P. S.
Article Title: Imaging CAR T-cell kinetics in solid tumors: Translational implications
Abstract: Success in solid tumor chimeric antigen receptor (CAR) T-cell therapy requires overcoming several barriers, including lung sequestration, inefficient accumulation within the tumor, and target-antigen heterogeneity. Understanding CAR T-cell kinetics can assist in the interpretation of therapy response and limitations and thereby facilitate developing successful strategies to treat solid tumors. As T-cell therapy response varies across metastatic sites, the assessment of CAR T-cell kinetics by peripheral blood analysis or a single-site tumor biopsy is inadequate for interpretation of therapy response. The use of tumor imaging alone has also proven to be insufficient to interpret response to therapy. To address these limitations, we conducted dual tumor and T-cell imaging by use of a bioluminescent reporter and positron emission tomography in clinically relevant mouse models of pleural mesothelioma and non-small cell lung cancer. We observed that the mode of delivery of T cells (systemic versus regional), T-cell activation status (presence or absence of antigen-expressing tumor), and tumorantigen expression heterogeneity influence T-cell kinetics. The observations from our study underscore the need to identify and develop a T-cell reporter-in addition to standard parameters of tumor imaging and antitumor efficacy-that can be used for repeat imaging without compromising the efficacy of CAR T cells in vivo.
Keywords: immunotherapy; reporter gene; adoptive transfer; microenvironment; pet; lymphocytes; therapy; checkpoint blockade; noninvasive detection; mesothelin overexpression
Journal Title: Molecular Therapy - Oncolytics
Volume: 22
ISSN: 2372-7705
Publisher: Cell Press  
Date Published: 2021-09-01
Start Page: 355
End Page: 367
Language: English
ACCESSION: WOS:000701676000028
DOI: 10.1016/j.omto.2021.06.006
PROVIDER: wos
PMCID: PMC8426175
PUBMED: 34553024
Notes: Article -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Vladimir Ponomarev
    123 Ponomarev
  2. Maxim A Moroz
    30 Moroz
  3. Aurore Ornella Lauriane Morello
    14 Morello
  4. Jasmeen Kaur Saini
    12 Saini
  5. Rachid Hocine Hocine
    2 Hocine
  6. Rebecca Bellis
    11 Bellis